Cauda equina syndrome (CES) is the most catastrophic missed diagnosis in back pain — it is a spinal surgical emergency with a narrow therapeutic window. The cauda equina (horse's tail) is the bundle of nerve roots below L1 that innervates the lower limbs, bladder, bowel, and perineum. Compression (most commonly from a large central disc prolapse at L4/5 or L5/S1) causes rapidly progressive neurological deficit. The surgical window for meaningful recovery is approximately 48 hours — delays beyond this produce permanent paralysis, bladder/bowel dysfunction, and sexual dysfunction. NICE mandates same-day MRI for suspected CES. The GP's clinical rule: ask every back pain patient about bladder (retention = most specific sign — painless inability to pass urine), bowel, and saddle area sensation at every consultation. A positive answer to any of these → 999 immediately. Bilateral leg symptoms, even mild, in a back pain patient must also raise concern.

NICE NG59 explicitly states: "Do not offer imaging for non-specific low back pain." This is a major departure from historical practice and is frequently misunderstood by patients and clinicians alike. The evidence base is clear: routine MRI in back pain patients without red flags increases catastrophising, disability, and healthcare utilisation without improving outcomes. Degenerative disc changes (disc bulges, facet joint OA, Modic changes) are found in over 80% of pain-free adults over 40 on MRI — they are radiological variants of ageing, not pathological findings requiring treatment. Telling a patient they have a "bulging disc" or "wear and tear changes" significantly increases their pain beliefs, reduces physical activity, and promotes disability behaviour. The GP communication task is to explain that absence of imaging is the evidence-based approach, and that the spine is strong and movement is healing.

The STarT Back Tool (Keele University) is the NICE-recommended prognostic tool for stratified care in non-specific LBP. It identifies patients at high risk of chronicity due to psychosocial factors (the high-risk group) who need CBT-informed physiotherapy rather than standard physiotherapy. The large RCT by Hill et al. (2011, Lancet) demonstrated that STarT Back-stratified care produced better outcomes and was more cost-effective than undifferentiated usual care. High-risk patients treated with standard physiotherapy alone show minimal improvement — they need simultaneous psychological intervention (CBT, acceptance and commitment therapy, mindfulness-based interventions) to address catastrophising and fear-avoidance. The tool takes 2 minutes to complete and is available online. GPs should complete it at the first chronic LBP consultation.

The Schober test for lumbar flexion restriction is the key clinical examination for ankylosing spondylitis in a young patient with back pain and morning stiffness. A lumbar flexion increment of <5 cm (from 0 to ≥5 cm increase in a 10 cm baseline interval) is highly specific for restricted lumbar mobility, consistent with spondyloarthropathy. Combined with elevated CRP and HLA-B27 positivity, this warrants urgent rheumatology referral for MRI sacroiliac joints. Ankylosing spondylitis affects 0.1–0.5% of the population, predominantly young males, and causes irreversible spinal fusion if untreated — but responds dramatically to NSAIDs (near-complete symptomatic response within 48 hours is almost pathognomonic) and biologics (TNF inhibitors). The average diagnostic delay for ankylosing spondylitis is 7–10 years — a significant and preventable failure in primary care.

The NICE NG59 recommendation against opioids for non-specific chronic low back pain is based on robust evidence that opioids produce minimal pain reduction (<10 mm on 100 mm VAS at 1 year) while causing significant harms: dependence (30% of long-term users develop opioid use disorder), opioid-induced hyperalgesia (opioids paradoxically increase pain sensitivity with chronic use), constipation, cognitive impairment, falls (especially in elderly), sexual dysfunction (opioid-induced androgen deficiency), and overdose risk. The average GP practice in the UK has 5–10% of chronic pain patients on long-term opioids — many of these patients would benefit from a structured opioid tapering programme combined with psychologically-informed physiotherapy. Opioid tapering for CLBP is an active RCGP GP guidance priority and is specifically tested in SCA examination scenarios. A key phrase for the SCA: "I can help you come off these medications — they may actually be making your pain worse in the long run."

Exercise is the single most evidence-based treatment for chronic low back pain — Cochrane systematic reviews of >200 RCTs demonstrate that exercise produces moderate-to-large improvements in pain and function in CLBP. The type of exercise is less important than adherence and consistency — patients should be encouraged to choose an activity they enjoy (swimming, walking, yoga, tai chi) rather than a specific "back exercise" programme, because enjoyment predicts adherence and adherence predicts outcome. The neurobiological mechanisms by which exercise reduces chronic pain include: endogenous opioid release, central pain inhibition (reduced central sensitisation), anti-inflammatory cytokine production, improved sleep, and mood enhancement via serotonin/dopamine. The GP's most important CLBP communication task is to explain that movement does not damage the back — the spine is a strong structure designed for movement, and pain does not equal damage in CLBP.

The "boom-and-bust" cycle is one of the most important concepts in chronic pain self-management — patients with CLBP frequently overdo activities on "good days" (boom), experience a pain flare from overexertion (bust), then rest for days (which deconditions them further). This cycle gradually escalates disability. Pacing (doing a set quota of activity regardless of pain level — not stopping when pain increases, not overdoing when pain is low) breaks this cycle. The concept comes from operant pain management theory (Fordyce, 1976) and is the foundation of all evidence-based pain management programmes. Teaching pacing explicitly in a GP consultation takes 3–5 minutes and is one of the highest-impact behavioural interventions available in primary care for CLBP. The pain toolkit (paintoolkit.org) is a free resource developed by Pete Moore (a chronic pain patient) that encapsulates all these principles in patient-friendly language.

The Oswestry Disability Index (ODI) is the gold standard patient-reported outcome measure (PROM) for low back pain — it is a 10-item questionnaire covering personal care, lifting, walking, sitting, standing, sleeping, social life, travelling, and pain intensity. Scores: 0–20% = minimal disability; 21–40% = moderate; 41–60% = severe; 61–80% = crippled; 81–100% = bedbound. Documenting ODI at baseline and at 3-month intervals provides an objective functional measure to guide escalation decisions, evidence treatment response, and support referral justification. Significant improvement is defined as ≥10-point reduction. For the SCA examination, being able to name a validated functional outcome measure for back pain and explain its clinical application demonstrates clinical knowledge at examiner-quality level. The Roland Morris Disability Questionnaire (24-item) is an alternative PROM that is simpler to complete.